Company
Genomenon
Genomenon structures the biomedical literature into the real-world evidence precision medicine programs and clinical labs need.
Also known as Genomenon, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Ann Arbor, Michigan, United States
- Founded
- 2014
- Customers
- clinical labs and biopharma drug programs
- Legal name
- Genomenon, Inc.
- genomenon.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Genomenon is an AI-driven, genomic intelligence company. Our mission is to save and improve lives by making genomic information actionable. We organize the world’s genomic knowledge and put it at the fingertips of clinicians to help diagnose and treat patients suffering from rare diseases and cancer and to help precision medicine companies create targeted therapies for diseases.
Funding snapshot
- Total raised
- $28.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $6M2026-07-15
Funding rounds
- Round, 2026
- $6M2026-07-15, SEC form D sold, 30 investors
- Round, 2024
- $5.5M2024-05-01, SEC form D sold, 30 investors
- Round, 2022
- $20M2022-02-24, SEC form D sold, 23 investors
- Round, 2020
- $2.9M2020-05-15, SEC form D sold, 36 investors
- Round, 2015
- $446K2015-08-06, SEC form D sold, 11 investors
Products
- Web
- Cancer Knowledgebase
- Web
- Mastermind
Loading relationship preview